DAY 1 (July 14th Friday 2017)
8:00 – 9:00 am: BREAKFAST AND REGISTRATION
Session 1: Medical Oncology issues
Speakers: Dr.AdamBrufsky, Univ of Pittsburgh; Dr. Prakash Vishnu, Mayo Clinic; Dr ShekarPatil, H C G , Bangalore.
9:00-9:30am: HER2 therapy in neo-adjuvant and metastatic setting
9:30- 10:00am: Indian breast cancer scenario – an Oncologist’s perspective
10:00- 10.10am: Q & A session
10:10- 10.30am: INAUGURAL CEREMONY & Tea Break
Session 2: Prognostic /Predictive markers in breast cancer
Role of new genomic testing in breast cancer
Speaker: Dr.Joseph Anderson, Genomic Health Inc, CA
10:30- 11:00am: Breast cancer prognostic factors: NCCN clinical practice guidelines
11:00- 11:20am: Staging: 8th edition AJCC staging manual; moving from anatomy to biology
11:20-11:30am: Q & A session and Comments by Drs.Brufsky, Vishnu and Patil
Session 3: Neo-adjuvant therapy changes; Radiation Oncologist perspective
Speaker: Dr.Al Taira, Sutter health, CA
11:30 – 12:00pm: Post- mastectomy radiation in small tumors: guidelines implications
12:00-12:10pm: Q & A session
Session 4: 12:10pm- 1:10pm: Case based discussions
ER/PR in breast cancer, reporting and CAP/ASCO guideline and HER2 testing issues
Speakers: Dr.Mamatha Chivukula, Sutter Health; Dr Rekha V Kumar, KMIO, Bangalore and Dr Aziza Nassar, Mayo Clinic
1:10pm- 2:00pm: Lunch
Session 5: Immunotherapy in breast cancer
2:00- 2:40pm: Triple negative breast cancers Biology and prevalence
Dr ShekarPatil, Dr.AdamBrufsky
2:40 -3:20pm: Role of Immunotherapy in breast cancer and introduction to new biomarkers PDL1
Speakers: Dr.MamathaChivukula and Dr.Prakash Vishnu.
3:20- 3:40pm: Q & A session
3:40 -4:00pm: Tea Break
4:00 -5:00pm: Paper & Poster presentation
7:00pm Onwards- Banquet.
Day 2 (July 15th, Saturday, 2017)
8:00 – 8:30 am: BREAKFAST
8:30 – 9:00 am: Career development forum for Medical students/pathologists –in-training – Dr.BruceSmoller.
Session 6: Proliferative lesions and related precursor lesions and molecular aspects
Speakers: Dr.AzizaNassar, Dr.Reena Bharadwaj, Department of Pathology, AFMC, Pune, Dr. MamathaChivukula and Dr.Sertac Kip, Geisinger Health
9:00– 9:20 am: Proliferative lesions
9:20- 9:50am: Flat epithelial atypia (FEA) and Atypical ductal epithelial hyperplasia (ADH) –seeking second opinion
9:50- 10:20am: Lobular neoplasia
10:20- 10:40 am: Molecular aspects of ductal and lobular in-situ lesions
10:40 – 11:00: Tea Break
Session 7: DCIS management from radiation and medical Oncologist’s perspective
11:00 am- 11:40 am: Speakers: Dr.AlTaira, and Dr.Prakash Vishnu,
11:40 11:50 am: Q&A session
Session 8: Clinical and Radiologic issues across the countries
Speakers: Dr. Jyotsna Rao ,Apollo, Hyderabad.
11:50– 12:20pm: Radiology and pathologic discordant issues
12: 20-12:30pm: Q & A session
12:30pm- 1:30pm: Lunch break
Session 9: Molecular aspects of In-situ lesions
Moderator: Aziza Nassar.
Speakers: Dr.Joseph Anderson and Dr.Sertac Kip.
1:30-1:50pm: The DCIS Score: a molecular prognostic assay
1:50 – 2:00pm: Comments by Dr.Sertac kip.
2:00- 2:10pm: Q & A session
Session 10: Role of Immunohistochemistry (IHC) in breast pathology (Case based session)
Speaker: Dr.AzizaNassar, Dr.BruceSmoller
2:10-3:00pm: Diagnostic issues of Immunohistochemistry (IHC)
3:00 pm – 3:10pm: Q & A session
Session 11: genetic and Molecular aspects of breast cancer
Speakers: Dr.Sertac Kip; Dr Aarthi Ravichandran, Senior scientist III, Strand life sciences, Bangalore.
3:20- 3:40pm: Role of Next-generation testing (NGS) in Breast cancer how far we have come?
3:50- 4:10pm: Next Generation Sequencing (NGS) & Personalised Medicine in Oncology.
4:10 pm – 4:20pm: Q & A session
4:30 pm: Final thoughts Dr.MamathaChivukula and Dr Dayananda Biligi.
Kindly note-Delegates can submit abstract for poster presentations in any topic concerned to Pathology ,but the paper presentation is restricted only to Breast pathology.